REFERENCES
2. Grines CL, Mehta S. ST-segment elevation myocardial infarction management: great strides but still room for improvement. Eur Heart J. 2021;42:4550-2.
3. Stone GW, Kappetein AP, Sabik JF, et al. Five-year outcomes after PCI or CABG for left main coronary disease. N Engl J Med. 2019;381:1820-30.
4. Ono M, Serruys PW, Hara H, et al. 10-year follow-up after revascularization in elderly patients with complex coronary artery disease. J Am Coll Cardiol. 2021;77:2761-73.
5. Ye Z, Xu Y, Tang L, et al. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model. Cardiovasc Diabetol. 2023;22:87.
6. Yang XG, Feng JT, Wang F, et al. Development and validation of a prognostic nomogram for the overall survival of patients living with spinal metastases. J Neurooncol. 2019;145:167-76.
7. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237-69.
8. Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148:e9-119.
9. Ocak N, Yesilaras M, Kilicaslan B, Eyler Y, Mutlu İ, Kutlu M. Comparing TIMI, HEART, and GRACE risk scores to predict angiographic severity of coronary artery disease and 30-day major adverse cardiac events in emergency department patients with NSTEACS. Prehospital Disaster Med. 2023;38:740-8.
10. Demirkıran A, Aydın C, Yılmaz A, et al. A new marker of coronary collateral flow in patients presenting with acute myocardial infarction. Eur Rev Med Pharmacol Sci. 2023;27:6256-63.
11. Katayama Y, Taruya A, Kashiwagi M, et al. No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction. Int J Cardiol Heart Vasc. 2022;38:100953.
12. Namazi M, Mahmoudi E, Safi M, et al. The no-reflow phenomenon: is it predictable by demographic factors and routine laboratory data? Acta Biomed. 2021;92:e2021297.
13. Perera D, Clayton T, O'Kane PD, et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022;387:1351-60.
14. Tang L, Wu M, Xu Y, et al. Multimodal data-driven prognostic model for predicting new-onset ST-elevation myocardial infarction following emergency percutaneous coronary intervention. Inflamm Res. 2023;72:1799-809.
15. Zhong L, Min J, Zhang J, Hu B, Qian C. Risk prediction models for successful discontinuation in acute kidney injury undergoing continuous renal replacement therapy. iScience. 2024;27:110397.
16. Fazel R, Joseph TI, Sankardas MA, et al. Comparison of reperfusion strategies for ST-segment-elevation myocardial infarction: a multivariate network meta-analysis. J Am Heart Assoc. 2020;9:e015186.
17. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87-165.
18. Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133:1135-47.
19. Song J, Liu Y, Wang W, et al. A nomogram predicting 30-day mortality in patients undergoing percutaneous coronary intervention. Front Cardiovasc Med. 2022;9:897020.
20. Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017;120:229-43.
21. Leoncini M, Toso A, Maioli M, Tropeano F, Bellandi F. Statin treatment before percutaneous cononary intervention. J Thorac Dis. 2013;5:335-42.
22. Zachariah P, Johnson CL, Halabi KC, et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children's hospital in New York City, New York. JAMA Pediatr. 2020;174:e202430.
23. Cockburn J, Kemp T, Ludman P, et al. Percutaneous coronary intervention in octogenarians: a risk scoring system to predict 30-day outcomes in the elderly. Catheter Cardiovasc Interv. 2021;98:1300-7.
24. Kleinbongard P, Gedik N, Witting P, Freedman B, Klöcker N, Heusch G. Pleiotropic, heart rate-independent cardioprotection by ivabradine. Br J Pharmacol. 2015;172:4380-90.
25. Halliday BP, Wassall R, Lota AS, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2019;393:61-73.
26. Aro AL, Reinier K, Rusinaru C, et al. Electrical risk score beyond the left ventricular ejection fraction: prediction of sudden cardiac death in the Oregon Sudden Unexpected Death Study and the Atherosclerosis Risk in Communities Study. Eur Heart J. 2017;38:3017-25.
27. Parikh KS, Greiner MA, Suzuki T, et al. Resting heart rate and long-term outcomes among the African American population: insights from the jackson heart study. JAMA Cardiol. 2017;2:172-80.
28. O'Hare C, Kuh D, Hardy R. Association of early-life factors with life-course trajectories of resting heart rate: more than 6 decades of follow-up. JAMA Pediatr. 2018;172:e175525.
29. Aziz F, Malek S, Ibrahim KS, et al. Short- and long-term mortality prediction after an acute ST-elevation myocardial infarction (STEMI) in Asians: a machine learning approach. PLoS ONE. 2021;16:e0254894.
30. Gao J, Lu Y, Ashrafi N, Domingo I, Alaei K, Pishgar M. Prediction of sepsis mortality in ICU patients using machine learning methods. BMC Med Inform Decis Mak. 2024;24:228.
31. Tan J, Zhang Z, He Y, et al. Development and validation of a risk prediction model for osteoporosis in elderly patients with type 2 diabetes mellitus: a retrospective and multicenter study. BMC Geriatr. 2023;23:698.
